CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $5.47 billion. The enterprise value is $3.89 billion.
| Market Cap | 5.47B |
| Enterprise Value | 3.89B |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 96.69 million shares outstanding. The number of shares has increased by 10.33% in one year.
| Current Share Class | 96.69M |
| Shares Outstanding | 96.69M |
| Shares Change (YoY) | +10.33% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 78.62% |
| Float | 96.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 408.37 |
| Forward PS | 71.59 |
| PB Ratio | 3.13 |
| P/TBV Ratio | 3.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 290.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.85, with a Debt / Equity ratio of 0.45.
| Current Ratio | 17.85 |
| Quick Ratio | 17.79 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.09% and return on invested capital (ROIC) is -325.94%.
| Return on Equity (ROE) | -26.09% |
| Return on Assets (ROA) | -14.20% |
| Return on Invested Capital (ROIC) | -325.94% |
| Return on Capital Employed (ROCE) | -21.12% |
| Weighted Average Cost of Capital (WACC) | 12.18% |
| Revenue Per Employee | $34,076 |
| Profits Per Employee | -$1.15M |
| Employee Count | 393 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.03 million in taxes.
| Income Tax | 3.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.25% in the last 52 weeks. The beta is 1.76, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -4.25% |
| 50-Day Moving Average | 53.03 |
| 200-Day Moving Average | 53.32 |
| Relative Strength Index (RSI) | 55.24 |
| Average Volume (20 Days) | 1,546,997 |
Short Selling Information
The latest short interest is 18.77 million, so 19.41% of the outstanding shares have been sold short.
| Short Interest | 18.77M |
| Short Previous Month | 18.74M |
| Short % of Shares Out | 19.41% |
| Short % of Float | 19.50% |
| Short Ratio (days to cover) | 12.58 |
Income Statement
In the last 12 months, CRSP had revenue of $13.39 million and -$451.14 million in losses. Loss per share was -$4.76.
| Revenue | 13.39M |
| Gross Profit | -461.80M |
| Operating Income | -531.87M |
| Pretax Income | -448.11M |
| Net Income | -451.14M |
| EBITDA | -513.17M |
| EBIT | -531.87M |
| Loss Per Share | -$4.76 |
Balance Sheet
The company has $2.36 billion in cash and $783.75 million in debt, with a net cash position of $1.58 billion or $16.35 per share.
| Cash & Cash Equivalents | 2.36B |
| Total Debt | 783.75M |
| Net Cash | 1.58B |
| Net Cash Per Share | $16.35 |
| Equity (Book Value) | 1.75B |
| Book Value Per Share | 18.07 |
| Working Capital | 2.24B |
Cash Flow
In the last 12 months, operating cash flow was -$369.58 million and capital expenditures -$1.74 million, giving a free cash flow of -$371.33 million.
| Operating Cash Flow | -369.58M |
| Capital Expenditures | -1.74M |
| Depreciation & Amortization | 18.69M |
| Net Borrowing | 600.00M |
| Free Cash Flow | -371.33M |
| FCF Per Share | -$3.84 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,971.53% |
| Pretax Margin | -3,346.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.33% |
| Shareholder Yield | -10.33% |
| Earnings Yield | -8.25% |
| FCF Yield | -6.79% |
Analyst Forecast
The average price target for CRSP is $87.56, which is 54.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $87.56 |
| Price Target Difference | 54.81% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 460.54% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 2.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.68 |
| Piotroski F-Score | 2 |